Back to News
Market Impact: 0.18
Bronstein, Gewirtz & Grossman LLC Urges Regeneron Pharmaceuticals, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
Source: globenewswire.com
Legal & LitigationCompany Fundamentals

Investor-rights law firm Bronstein, Gewirtz & Grossman announced that a class action lawsuit has been filed against Regeneron Pharmaceuticals (REGN) and certain officers. The filing itself is not quantified, but it introduces potential legal overhang and liability risk that could weigh modestly on sentiment.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly negative
Sentiment Score
-0.25
Ticker Sentiment
REGN-0.85
More News
- World Leaders Converge on United Nations General Assembly
- The Zombie Office Apocalypse
- Intel surges 12% as CPU stocks rally. Here's what's driving the move
- Paramount and state AGs will settle lawsuit, allowing Warner Bros. merger to proceed, reports say
- Why is Labcorp stock sliding today?
- Paramount settles with US states in step towards merger with Warner Bros